Cargando…
Correction: A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057450/ https://www.ncbi.nlm.nih.gov/pubmed/30042830 http://dx.doi.org/10.18632/oncotarget.25775 |
| _version_ | 1783341530253099008 |
|---|---|
| author | Satake, Hironaga Sunakawa, Yu Miyamoto, Yuji Nakamura, Masato Nakayama, Hiroshi Shiozawa, Manabu Makiyama, Akitaka Kobayashi, Kazuma Kubota, Yutaro Mori, Misuzu Kotaka, Masahito Takagane, Akinori Gotoh, Masahiro Takeuchi, Masahiro Fujii, Masashi Ichikawa, Wataru Sekikawa, Takashi |
| author_facet | Satake, Hironaga Sunakawa, Yu Miyamoto, Yuji Nakamura, Masato Nakayama, Hiroshi Shiozawa, Manabu Makiyama, Akitaka Kobayashi, Kazuma Kubota, Yutaro Mori, Misuzu Kotaka, Masahito Takagane, Akinori Gotoh, Masahiro Takeuchi, Masahiro Fujii, Masashi Ichikawa, Wataru Sekikawa, Takashi |
| author_sort | Satake, Hironaga |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6057450 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-60574502018-07-24 Correction: A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11 Satake, Hironaga Sunakawa, Yu Miyamoto, Yuji Nakamura, Masato Nakayama, Hiroshi Shiozawa, Manabu Makiyama, Akitaka Kobayashi, Kazuma Kubota, Yutaro Mori, Misuzu Kotaka, Masahito Takagane, Akinori Gotoh, Masahiro Takeuchi, Masahiro Fujii, Masashi Ichikawa, Wataru Sekikawa, Takashi Oncotarget Correction Impact Journals LLC 2018-07-06 /pmc/articles/PMC6057450/ /pubmed/30042830 http://dx.doi.org/10.18632/oncotarget.25775 Text en Copyright: © 2018 Satake et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited. |
| spellingShingle | Correction Satake, Hironaga Sunakawa, Yu Miyamoto, Yuji Nakamura, Masato Nakayama, Hiroshi Shiozawa, Manabu Makiyama, Akitaka Kobayashi, Kazuma Kubota, Yutaro Mori, Misuzu Kotaka, Masahito Takagane, Akinori Gotoh, Masahiro Takeuchi, Masahiro Fujii, Masashi Ichikawa, Wataru Sekikawa, Takashi Correction: A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11 |
| title | Correction: A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11 |
| title_full | Correction: A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11 |
| title_fullStr | Correction: A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11 |
| title_full_unstemmed | Correction: A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11 |
| title_short | Correction: A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11 |
| title_sort | correction: a phase ii trial of 1st-line modified-folfoxiri plus bevacizumab treatment for metastatic colorectal cancer harboring ras mutation: jaccro cc-11 |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057450/ https://www.ncbi.nlm.nih.gov/pubmed/30042830 http://dx.doi.org/10.18632/oncotarget.25775 |
| work_keys_str_mv | AT satakehironaga correctionaphaseiitrialof1stlinemodifiedfolfoxiriplusbevacizumabtreatmentformetastaticcolorectalcancerharboringrasmutationjaccrocc11 AT sunakawayu correctionaphaseiitrialof1stlinemodifiedfolfoxiriplusbevacizumabtreatmentformetastaticcolorectalcancerharboringrasmutationjaccrocc11 AT miyamotoyuji correctionaphaseiitrialof1stlinemodifiedfolfoxiriplusbevacizumabtreatmentformetastaticcolorectalcancerharboringrasmutationjaccrocc11 AT nakamuramasato correctionaphaseiitrialof1stlinemodifiedfolfoxiriplusbevacizumabtreatmentformetastaticcolorectalcancerharboringrasmutationjaccrocc11 AT nakayamahiroshi correctionaphaseiitrialof1stlinemodifiedfolfoxiriplusbevacizumabtreatmentformetastaticcolorectalcancerharboringrasmutationjaccrocc11 AT shiozawamanabu correctionaphaseiitrialof1stlinemodifiedfolfoxiriplusbevacizumabtreatmentformetastaticcolorectalcancerharboringrasmutationjaccrocc11 AT makiyamaakitaka correctionaphaseiitrialof1stlinemodifiedfolfoxiriplusbevacizumabtreatmentformetastaticcolorectalcancerharboringrasmutationjaccrocc11 AT kobayashikazuma correctionaphaseiitrialof1stlinemodifiedfolfoxiriplusbevacizumabtreatmentformetastaticcolorectalcancerharboringrasmutationjaccrocc11 AT kubotayutaro correctionaphaseiitrialof1stlinemodifiedfolfoxiriplusbevacizumabtreatmentformetastaticcolorectalcancerharboringrasmutationjaccrocc11 AT morimisuzu correctionaphaseiitrialof1stlinemodifiedfolfoxiriplusbevacizumabtreatmentformetastaticcolorectalcancerharboringrasmutationjaccrocc11 AT kotakamasahito correctionaphaseiitrialof1stlinemodifiedfolfoxiriplusbevacizumabtreatmentformetastaticcolorectalcancerharboringrasmutationjaccrocc11 AT takaganeakinori correctionaphaseiitrialof1stlinemodifiedfolfoxiriplusbevacizumabtreatmentformetastaticcolorectalcancerharboringrasmutationjaccrocc11 AT gotohmasahiro correctionaphaseiitrialof1stlinemodifiedfolfoxiriplusbevacizumabtreatmentformetastaticcolorectalcancerharboringrasmutationjaccrocc11 AT takeuchimasahiro correctionaphaseiitrialof1stlinemodifiedfolfoxiriplusbevacizumabtreatmentformetastaticcolorectalcancerharboringrasmutationjaccrocc11 AT fujiimasashi correctionaphaseiitrialof1stlinemodifiedfolfoxiriplusbevacizumabtreatmentformetastaticcolorectalcancerharboringrasmutationjaccrocc11 AT ichikawawataru correctionaphaseiitrialof1stlinemodifiedfolfoxiriplusbevacizumabtreatmentformetastaticcolorectalcancerharboringrasmutationjaccrocc11 AT sekikawatakashi correctionaphaseiitrialof1stlinemodifiedfolfoxiriplusbevacizumabtreatmentformetastaticcolorectalcancerharboringrasmutationjaccrocc11 |